Axis Research Mind, July 2010, Pages: 410
discovery applications discussed in the report are:
- Cell Therapy and RegenerativeMedicine
- High-Content Screening Assays and Toxicology
- Replacement of Damaged Cells
The report centers on major current
Select Biosciences Ltd, April 2010, Pages: 52
and Bottom-Up Picture of the marketplace for the utilization of stemcells for drug discovery/toxicity screening efforts as well as research for regenerativemedicine applications.
Specific Topics Covered
BioInformant, Nov 2011, Pages: 109
is the potential for use of stemcells in regenerativemedicine to treat conditions ranging from diabetes, to cardiovascular disease and neurological disorders. Additionally, the ability to use stemcells to improve
Jain PharmaBiotech, Feb 2012, Pages: 1008
This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine. Hematopoietic stemcell transplantation
Axis Research Mind, July 2010, Pages: 472
THEORIES
LOST VISION RESTORED - THANKS TO UMBILICAL STEMCELL THERAPIES
INDIA THE NEXT POTENTIAL STEMCELL MARKET - CORDLIFE
REGENERATIVEMEDICINE GETS A BACKUP WITH STEMCELL TECHNOLOGY
ROMANIA STARTS ITS
Bizacumen Inc., Nov 2009, Pages: 231
RegenerativeMedicine to Overcome Donor Organs Shortage 8
Possible Scenarios 9
StemCell Research - Not Just Another Medical
Global Industry Analysts, Inc., Oct 2010, Pages: 381
17
Therapies Based on Human Cells and Tissues 17
Type-3 RegenerativeMedicine 18
Based on Embryonic StemCells
Axis Research Mind, July 2010, Pages: 468
. Besides information from government databases, company websites, press releases and published research reports are also used for estimates. Estimates have incorporated recessionary impact on the StemCells
Select Biosciences Ltd, March 2010, Pages: 204
cells which leverage their utilization for cellular therapy/regenerativemedicine.
This market report is built using data and analyses from Select Biosciences continual industry tracking
Select Biosciences Ltd, Jan 2009, Pages: 106
on the various clinical applications of mesenchymal stemcells (MSCs)—a key stemcell lineage of paramount importance for regenerativemedicine. A Major Focus of this Report is on the Market Landscape
Industry Experts, July 2010, Pages: 216
Embryonic StemCell Therapy for Spinal Cord Injuries Nanotechnology for RegenerativeMedicine: Nanomaterials for StemCell Imaging Therapeutic Potential of hESC in Parkinson’s disease 1.6 Key Global
Axis Research Mind, May 2011, Pages: 692
OF STEMCELLS FOR REGENERATIVEMEDICINE AND STEMCELL BANKING
CORD BLOOD AMERICA, INC. ANNOUNCES PURCHASE OF MINORITY INTEREST IN VIDAPLUS EXPECTED TO GAIN REVENUE AND POPULARITY IN EUROPE
INDUCED
Global Industry Analysts, Inc., Feb 2011, Pages: 566
PS 14
RegenerativeMedicine 14
Establishing iPS Cell Banks 15
Intractable and Congenital Disease Treatments 15
Repairing Organs 15
Embryonic StemCells to Transfigure the Field of Medicine 15
Lack
Select Biosciences Ltd, Jan 2010, Pages: 113
This is the latest and most up-to-date Market Report from Select Biosciences addressing the cellular therapy space. Select Biosciences’ industry coverage of the stemcells space is broad
Industry Experts, Oct 2011, Pages: 282
for congenital heart defect or for future unforeseen and sudden occurrences, such as a serious heart attack. Latest scientific evidence offered by regenerativemedicine has proved that using one's own stemcells
Future Medicine Ltd, July 2010, Pages: 122
in 21st century drug discovery
Rebecca K Rowntree, John D McNeish
SPECIAL REPORTS:
- Regulatory considerations for the development of autologous induced pluripotent stemcell therapies
Melissa K
Elsevier Science and Technology, Dec 2010, Pages: 1202
and instituions in StemCell Biology, Bioengineering, and Developmental Biology
- The first of its kind to offer an advanced understanding of the latest technologies in regenerativemedicine
- New discoveries from
